Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale

被引:79
|
作者
Rowe, Christopher C. [1 ,2 ]
Jones, Gareth [1 ]
Dore, Vincent [1 ,3 ]
Pejoska, Svetlana [1 ]
Margison, Laura [1 ]
Mulligan, Rachel S. [1 ]
Chan, J. Gordon [1 ]
Young, Kenneth [1 ]
Villemagne, Victor L. [1 ,2 ,4 ]
机构
[1] Austin Hlth, Dept Mol Imaging, 145 Studley Rd, Melbourne, Vic 3084, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] CSIRO Hlth & Biosecur, Brisbane, Qld, Australia
[4] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
Alzheimer's disease; centiloid; amyloid imaging; beta-amyloid; standardization; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; PROSPECTIVE COHORT; QUANTIFICATION; RADIOLIGAND; BRAIN; F-18-AZD4694; VARIABILITY; DEPOSITION; DEMENTIA;
D O I
10.2967/jnumed.115.171595
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A common quantitative output value for PET measures of beta-amyloid (A beta) binding across tracers and methods would allow better comparison of data across sites and application of universal diagnostic and prognostic values. A method has recently been developed that generates a unit of measurement called the centiloid. We applied this method to 2-[2-F-18-fluoro-6-(methylamino)-3-pyridinyl]-1-benzofuran-5-ol (F-18-NAV4694) and C-11-Pittsburgh compound B (C-11-PiB) A beta images to derive the scaling factor required to express tracer binding in centiloids. Methods: Fifty-five participants, including 10 young controls (33 +/- 7 y old), underwent both C-11-PiB and F-18-NAV4694 imaging no more than 3 mo apart, with the images acquired 50-70 min after tracer injection. The images were spatially normalized and analyzed using the standard centiloid method and regions (cortex and whole-cerebellum reference) downloaded from the Global Alzheimer Association Interactive Network website. Results: SUV ratios (SUVRs) showed a strong correlation in tracer binding (F-18-NAV4694 SUVR = 1.09 x C-11-PiB SUVR - 0.08, R-2 = 0.99). The equation to convert F-18-NAV4694 to centiloids [100 x (F-18-NAV4694 SUVR - 1.028)/1.174] was similar to a published equation for C-11-PiB [100 x (C-11-PiB SUVR - 1.009)/1.067]. In the young controls, the variance ratio (F-18-NAV4694 centiloid SD divided by C-11-PiB centiloid SD) was 0.85. Conclusion: The results for both C-11-PiB and F-18-NAV4694 can now be expressed in centiloids, an important step that should allow better clinical and research use of A beta imaging. The standard centiloid method also showed that F-18-NAV4694 has slightly higher A beta binding and lower variance than C-11-PiB, important properties for detecting early A beta deposition and change over time.
引用
收藏
页码:1233 / 1237
页数:5
相关论文
共 50 条
  • [41] β-amyloid Imaging Agents for PET - Preclinical Evaluation of [11C]PIB and [18F]Flutemetamol
    Pakkanen, A.
    Rokka, J.
    Wilson, I.
    Farrar, G.
    Solin, O.
    Rinne, J. O.
    Haaparanta, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S396 - S396
  • [42] 11C-PIB PET of inclusion body myositis: Molecular imaging of amyloid beta expression improving imaging-pathology correlations
    Li, Ke
    Dang, Haodan
    Shi, Qiang
    CLINICAL NEUROPATHOLOGY, 2020, 39 (05) : 243 - 244
  • [43] Microglial activation and amyloid deposition in Alzheimer's disease:: An 11C-PK11195 and 11C-PIB PET study
    Edison, P
    Archer, H
    Hinz, R
    Gerhard, A
    Hammers, A
    Tai, YF
    Turkheimer, F
    Pavese, N
    Fox, N
    Rossor, M
    Brooks, DJ
    NEUROLOGY, 2006, 66 (05) : A122 - A122
  • [44] Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
    Okello, A.
    Koivunen, J.
    Edison, P.
    Archer, H. A.
    Turkheimer, F. E.
    Nagren, K.
    Bullock, R.
    Walker, Z.
    Kennedy, A.
    Fox, N. C.
    Rossor, M. N.
    Rinne, J. O.
    Brooks, D. J.
    NEUROLOGY, 2009, 73 (10) : 754 - 760
  • [45] Feasibility and Optimization of Radiomic Settings for Differentiation of HC and AD using 18F-FDG and 11C-PIB PET Scans
    Peretti, D.
    Kolinger, G.
    Pfaehler, E.
    Reesink, F.
    de Jong, B.
    De Deyn, P.
    Dierckx, R.
    Garcia, D. Vallez
    Boellaard, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S511 - S512
  • [46] 18F-FDG and 11C-PIB PET/TC findings in status epilepticus in the setting of a patient with mild cognitive impairment
    Pombo-Lopez, M.
    Bota-Bota, A.
    Martinez-Rodriguez, I.
    Gomez-de la Fuente, F.
    Jimenez-Bonilla, J.
    Quirce, R.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2025, 44 (02):
  • [47] 11C-PIB and 18F-FDG PET/CT in the differential diagnosis of frontotemporal lobar degeneration and Alzheimer's Disease
    Jimenez-Bonilla, J. F.
    Banzo, I.
    De Arcocha-Torres, M.
    Ortega-Nava, F.
    Martinez-Rodriguez, I.
    Quirce, R.
    Rodriguez, E.
    Sanchez-Juan, P.
    Bravo-Ferrer, Z.
    Lavado-Perez, C.
    Lopez-Defillo, J.
    Carril, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S324 - S324
  • [48] Repurposing stilbene derivatives as myelin radiotracers for PET imaging: a study comparing 11C-MeDAS, 18F-florbetapir and 18F-florbetaben with the benzothiazole 11C-PiB
    Tonietto, M.
    Auvity, S.
    Caille, F.
    Bodini, B.
    Bottlaender, M.
    Tournier, N.
    Kuhnast, B.
    Stankoff, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 628 - 629
  • [49] Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease
    Villemagne, Victor L.
    Mulligan, Rachel S.
    Pejoska, Svetlana
    Ong, Kevin
    Jones, Gareth
    O'Keefe, Graeme
    Chan, J. Gordon
    Young, Kenneth
    Tochon-Danguy, Henri
    Masters, Colin L.
    Rowe, Christopher C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (06) : 983 - 989
  • [50] Amyloid deposition and metabolic dysfunction in Alzheimer's disease and mild cognitive impairment: An 11C-PIB and 18FDG PET study
    Edison, P
    Archer, H
    Hinz, R
    Hammers, A
    Tai, YF
    Pavese, N
    Fox, N
    Rossor, M
    Brooks, DJ
    NEUROLOGY, 2006, 66 (05) : A249 - A250